1. Home
  2. EMN vs RGEN Comparison

EMN vs RGEN Comparison

Compare EMN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMN
  • RGEN
  • Stock Information
  • Founded
  • EMN 1920
  • RGEN 1981
  • Country
  • EMN United States
  • RGEN United States
  • Employees
  • EMN N/A
  • RGEN N/A
  • Industry
  • EMN Major Chemicals
  • RGEN Medical/Dental Instruments
  • Sector
  • EMN Industrials
  • RGEN Health Care
  • Exchange
  • EMN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • EMN 9.2B
  • RGEN 8.0B
  • IPO Year
  • EMN 1993
  • RGEN N/A
  • Fundamental
  • Price
  • EMN $74.21
  • RGEN $118.85
  • Analyst Decision
  • EMN Buy
  • RGEN Buy
  • Analyst Count
  • EMN 13
  • RGEN 11
  • Target Price
  • EMN $99.46
  • RGEN $172.67
  • AVG Volume (30 Days)
  • EMN 2.1M
  • RGEN 736.8K
  • Earning Date
  • EMN 07-24-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • EMN 4.47%
  • RGEN N/A
  • EPS Growth
  • EMN 1.14
  • RGEN N/A
  • EPS
  • EMN 7.86
  • RGEN N/A
  • Revenue
  • EMN $9,362,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • EMN N/A
  • RGEN $13.93
  • Revenue Next Year
  • EMN $3.28
  • RGEN $14.35
  • P/E Ratio
  • EMN $9.45
  • RGEN N/A
  • Revenue Growth
  • EMN 2.79
  • RGEN 4.88
  • 52 Week Low
  • EMN $70.90
  • RGEN $102.97
  • 52 Week High
  • EMN $114.50
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • EMN 37.20
  • RGEN 39.78
  • Support Level
  • EMN $76.01
  • RGEN $120.68
  • Resistance Level
  • EMN $81.79
  • RGEN $135.30
  • Average True Range (ATR)
  • EMN 1.91
  • RGEN 4.93
  • MACD
  • EMN -0.60
  • RGEN -0.64
  • Stochastic Oscillator
  • EMN 10.71
  • RGEN 18.40

About EMN Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: